Lupin’s arm recalling 39,216 bottles of Lisinopril & Hydrochlorothiazide tablets from US

26 Aug 2019

Lupin’s American subsidiary -- Lupin Pharmaceuticals Inc is recalling 39,216 bottles of Lisinopril and Hydrochlorothiazide tablets USP, 10 mg/12.5 mg, 100 tablet bottle manufactured at its Pithampur facility from the US market. The reason for the recall is presence of foreign substance; product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles. The tablets are used for treatment of hypertension.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Related Lupin Ltd. Links:

Lupin Share Price

1048.15 -12.70 (-1.20%) Mar 04, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 618.65
Dr. Reddys Lab 4574.30
Lupin 1048.15
Piramal Enterprises 1956.90
Cadila Healthcare 449.00
View more..
Sensex vs Lupin
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback